Publications by authors named "Chunwei Xu"

Claim this Profile
P
Pyrotinib inhibits the tumorigenicity of HER2-positive non-small cell lung cancer by inducing ARIH1/ubiquitin/lysosome-dependent degradation of HER2.
Xiyue Li, Jiehong Wang, Shu Li, Jing Fang, Yue Hao, Chunwei Xu, Xue Zhu, Xun Wang

Cell Oncol (Dordr)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A machine learning-based framework for prognostic prediction and tumor microenvironment characterization of locally advanced cervical cancer with concurrent chemoradiotherapy.
Yue Feng, Zijian Sun, Yuqiang Li, Fang Wang, Qiyang Li, Chunwei Xu

NPJ Precis Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis of LVD versus PVE in treating liver cancer with an insufficient liver remnant.
Jiafei Che, Chunwei Xu, Xinhua Cui, Ying Xie, Huiqi Mo

J Chin Med Assoc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epithelial-Mesenchymal Transition States and Metabolic Reprogramming Related Signatures Predict Prognosis and Therapeutic Responses in HER2-Positive Breast Cancer.
Yuhui Zheng, Yinduo Zeng, Mengping Xi, Guoqiang Zhu, Jinyu Yang, Chunwei Xu

J Clin Lab Anal· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OKAIN: A comprehensive oncology knowledge base for the interpretation of clinically actionable alterations.
Zhenhua Yang, Chunwei Xu, Mingmin Wang, Xinxiu Meng, Kai Wang

Open Med (Wars)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study.
Zhengbo Song, Ziming Li, Yiping Zhang, Pingli Wang, Liyan Jiang, Xuewen Liu, Chunwei Xu

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-marketing safety of pralsetinib: a real-world disproportionality analysis based on the FDA adverse event reporting system database.
Zheng Shi, Keda Shao, Ke Wang, Manyi Xu, Xiayao Yu, Chunwei Xu

Int J Clin Pharm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleolar protein DCAF13 promotes non-small cell lung cancer cell proliferation via facilitating rDNA transcription and ribosome biogenesis.
Xiao-Min Wang, Meng-Dan Lv, Zhong-Jie Wu, Xiao-Hui Wu, Gu-Yuan Sun, Long Xu, Chun-Wei Xu

J Biol Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and clinical characteristics of mesothelioma in the Chinese population: a multicenter study.
Shengjie Yang, Yue Hao, Ke Wang, Haipeng Xu, Long Huang, Ling Xu, Xuefei Shi, Jingxun Wu, Chunwei Xu

Ther Adv Med Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Notch pathway defines an aggressive and immune-suppressive phenotype associated with checkpoint inhibitor resistance in pan-gastrointestinal adenocarcinomas.
Yang Luo, Roushu Wang, Yu Xu, Mengjiang He, Qiaoxia Zhou, Chunwei Xu, Xu Zhu

Clin Exp Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-oncology-microbiome axis in lung cancer: from carcinogenesis to therapy-a narrative review.
Mengyi Shen, Yueying Chen, Jiayan Chen, Jie Yin, Chunwei Xu

Transl Lung Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inclusion of anti-vascular therapy as a promising option for later-line treatment of malignant pleural mesothelioma: a retrospective study.
Keda Shao, Di Wu, Qian Wang, Dong Wang, Yue Hao, Jingxun Wu, Ling Xu, Xuefei Shi, Chunwei Xu

J Thorac Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erdafitinib inhibits the tumorigenicity of MDA-MB-231 triple-negative breast cancer cells by inducing TRIM25/ubiquitin-dependent degradation of FGFR4.
Qing Luo, Li Zhang, Yue Hao, Chunwei Xu, Xiaojia Wang, Xue Zhu

Breast Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: The influence of PD-L1 expression levels on the efficacy of combination therapy in thymic epithelial tumors.
Han Si, Xiaoshuang Fu, Yue Hao, Yina Wang, Gen Lin, Chunwei Xu

Clin Transl Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Design and Evaluation of Novel Peptide-Based PET Probe for Noninvasive Imaging of HER2 Expression in Breast Cancer.
Xu Guo, Chunwei Xu, Xue Zhu, Xiaojia Wang, Yue Hao, Xun Wang

J Med Chem· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination regimens as potential treatment of non-small-cell lung cancer patients with HER2 mutation in the real world: a multicenter study.
Yue Hao, Qian Wang, Ke Wang, Chengyu Chen, Chunwei Xu

Ther Adv Med Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy evaluation of tyrosine kinase inhibitors for advanced non-small cell lung cancer patients with leptomeningeal metastasis.
Yanhua Wang, Yue Hao, Manyi Xu, Lue Hong, Chunwei Xu

J Thorac Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lactate drives senescence-resistant lineages in hepatocellular carcinoma via histone H2B lactylation of NDRG1.
Lu Li, Jinyun Dong, Chunwei Xu, Shiqun Wang

Cancer Lett· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration.
Huijing Feng, Yang Xia, Wenxian Wang, Chunwei Xu, Qian Wang, Xuewen Liu, Jingxun Wu, Bingwei Xu, Ling Xu, Xuefei Shi, Xuelei Ma, Xixu Zhu

Cancer Biol Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus on cancer treatment-related lung injury.
Xinqing Lin, Hui Guo, Wei Zhao, Min Li, Gen Lin, Fei Xu, Yan Xu, Chunwei Xu

J Thorac Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-marketing safety of Adagrasib: a disproportionality analysis based on the FAERS database.
Zheng Shi, Xiayao Yu, Yifan Zhao, Keda Shao, Chunwei Xu

Expert Opin Drug Saf· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of fluorescence navigation combined with 3D imaging in precise liver resection: A systematic review and meta-analysis.
Chunwei Xu, Xinhua Cui, Jiafei Che, Xiaojing Shen, Dingchao Chen

Photodiagnosis Photodyn Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SplitFusion enables ultrasensitive gene fusion detection and reveals fusion variant-associated tumor heterogeneity.
Weiwei Bian, Baifeng Zhang, Zhengbo Song, Binyamin A Knisbacher, Yee Man Chan, Chunwei Xu

Patterns (N Y)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-gastrointestinal adenocarcinoma analysis uncovers the prognostic and immune correlates of ferroptosis-related genes.
Xiaochuan Dong, Yanyan Xie, Wenxi Chen, Mengjiang He, Hua Liu, Yu Xu, Chunwei Xu, Meili Xu

Transl Gastroenterol Hepatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of immune checkpoint inhibitor rechallenge in initial immunotherapy responders with advanced non-small cell lung cancer: A single-center retrospective study.
Manyi Xu, Yanhua Wang, Ke Wang, Yue Hao, Chunwei Xu

Invest New Drugs· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis